Zdrowie i gospodarka · 21/04/2005

FDA Releases Guidance on Electronic Labeling Submissions for Drug and Biological Applications

The Food and Drug Administration (FDA) has released a guidance document outlining the requirements for submitting the content of labeling for new drug applications, abbreviated new drug applications, and biological license applications in electronic format. This guidance is part of a series aimed at facilitating electronic regulatory submissions to the FDA.